Theory Paper IIIDrNB Cardiology – Theory Notes

CALCIUM MODIFICATION STRATEGIES IN CORONARY ARTERY DISEASE

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IDEFINITION AND CLINICAL SIGNIFICANCE

  • Angiographic Definition: Severe coronary calcification is defined angiographically as radiopacities visible without cardiac motion prior to contrast injection, typically involving both sides of the arterial lumen (“tram-track” appearance).
  • Clinical Imperative: Stent under-expansion (Minimum Stent Area less than 80 percent of reference lumen area or less than 4.5 to 5.0 mm2) caused by an unfractured circumferential calcium ring is the single strongest modifiable predictor of early Stent Thrombosis (ST) and late In-Stent Restenosis (ISR) / Target Lesion Revascularization (TLR).

IIINTRAVASCULAR IMAGING: THE FUJINO OCT CALCIUM SCORING SYSTEM (“RULE OF 5s”)

  • Superiority Over Angiography: Coronary angiography underestimates calcium presence and depth in nearly 50 percent of lesions; Intravascular Ultrasound (IVUS) or Optical Coherence Tomography (OCT) is recommended (Class I in ESC 2024 CCS Guidelines for complex lesions) to guide calcium modification.
  • The Validated OCT Calcium Score (Fujino et al., EuroIntervention 2018 — “Rule of 5s” / 0 to 4 Points): Because near-infrared light penetrates calcium without acoustic shadowing, OCT directly measures calcium thickness:
  • Maximum Calcium Arc greater than 180 degrees (>50% of circumference): 2 points.
  • Maximum Calcium Thickness greater than 0.5 mm: 1 point.
  • Continuous Calcium Length greater than 5.0 mm: 1 point.
  • Actionable Threshold: A total OCT Calcium Score of 4 points (meeting all three “Rule of 5s” criteria) strongly predicts severe stent under-expansion with plain balloons and mandates upfront plaque modification (IVL or Atherectomy) prior to stenting.
  • IVUS Calcium Assessment Criteria: Ultrasound reflects off calcium (producing bright echoes with posterior acoustic shadowing, preventing direct thickness measurement); high risk of under-expansion on IVUS is predicted by a superficial calcium arc greater than 270 degrees with length >=5 mm, 360-degree circumferential calcium, a calcified nodule, or an adjacent vessel diameter <3.5 mm.

IIIBALLOON-BASED STRATEGIES (NON-ABLATIVE)

  • Non-Compliant (NC) Balloons: High-pressure (18 to 24 atm) inflation; first-line for mild-to-moderate calcium (calcium arc <=180 degrees).
  • Cutting Balloons (Wolverine / Flextome) and Scoring Balloons (AngioSculpt / Scoreflex / NSE Alpha): Mount 3 to 4 longitudinal micro-surgical atherotomes (blades) or a helical nitinol scoring wire on the balloon surface, concentrating radial stress along focal lines to create controlled intimal micro-incisions, lower the pressure required to fracture calcium, and prevent balloon slippage (“melon-seeding”) in ostial or in-stent lesions.
  • Super-High-Pressure Twin-Layer Balloons (OPN NC): Dual-layer non-compliant balloon rated up to 35 to 40+ atm without dog-boning or pinhole rupture; used for resistant calcified lesions and under-expanded stents (evaluated in the ISAR-CALC trials).

IVATHEROABLATIVE STRATEGIES (ROTATIONAL, ORBITAL, AND LASER)

  • Rotational Atherectomy (Rotablator / RotaPro):
    • Mechanism (“Differential Cutting”): A front-cutting elliptical diamond-coated burr (1.25 to 2.0 mm) rotates concentrically at 140,000 to 160,000 RPM over a dedicated 0.009-inch RotaWire. Inelastic calcified plaque is pulverized into <5-micrometer microparticles (cleared by the reticuloendothelial system), while elastic healthy vascular tissue deflects away.
    • Primary Role and Technique: The gold standard for balloon-uncrossable or microcatheter-uncrossable severely calcified lesions. Contemporary best practice uses a burr-to-artery ratio of 0.5 to 0.6, a pecking motion (runs <15 to 20 seconds), avoidance of decelerations >5,000 RPM, and polishing runs (ablates only in the forward direction; never stop or trap the burr distal to an unablated tight lesion).
    • Orbital Atherectomy (Diamondback 360):
    • Mechanism (Centrifugal Crown Orbit): An eccentrically mounted 1.25 mm diamond-coated crown orbits via centrifugal force at 80,000 RPM (low speed) or 120,000 RPM (high speed) over a 0.014-inch ViperWire.
    • Advantages and Contraindications: A single 1.25 mm crown treats vessels from 2.5 to 4.0 mm by increasing orbital diameter with rotational speed or slower advancement, ablates bi-directionally (both forward and backward, reducing entrapment risk), and maintains continuous pulsatile blood flow around the small crown during sanding. (Strictly contraindicated in severe vessel angulation >45–60 degrees, dissections, or saphenous vein grafts.)
    • Excimer Laser Coronary Atherectomy (ELCA):
    • Mechanism: Emits pulsed 308-nm ultraviolet light that modifies tissue via photochemical (breaking carbon-carbon bonds), photothermal (intracellular water vaporization), and photomechanical (acoustic vapor-bubble expansion/collapse) energy.
    • Primary Roles: (1) Balloon-uncrossable chronic total occlusions / calcified lesions where a RotaWire/ViperWire cannot be exchanged (ELCA advances directly over any standard 0.014-inch guidewire), and (2) Refractory Stent Under-Expansion caused by unfractured calcium behind a previously deployed stent.
Modality Primary Mechanism Ablates Bi-Directionally? Reaches Deep Medial Calcium? Ideal Clinical Niche
Rotational Atherectomy (RotaPro) Concentric differential cutting (140–160k RPM) No (Forward only) No (Superficial/luminal) Balloon-uncrossable or severe ostial/angulated calcified lesions
Orbital Atherectomy (Diamondback) Centrifugal orbital sanding (80k / 120k RPM) Yes (Forward & backward) No (Superficial/luminal) Large-vessel (3.0–4.0 mm) crossable concentric superficial calcium
Intravascular Lithotripsy (IVL) Acoustic sonic pressure waves (~50 atm equivalent) N/A (Balloon at 4 atm) Yes (Both superficial & deep) Crossable concentric (>180°), thick (>0.5 mm), deep calcium, bifurcations, & under-expanded stents
Excimer Laser (ELCA) 308-nm UV photoablation + acoustic cavitations Yes Behind stent struts (with contrast) Uncrossable lesions on standard 0.014” wire & stent under-expansion

VINTRAVASCULAR LITHOTRIPSY (IVL — SHOCKWAVE C2+)

  • Biophysical Mechanism: A semi-compliant balloon catheter (inflated gently at 4 atm for wall apposition) houses lithotripsy emitters that vaporize saline-contrast fluid to generate unfocused, circumferential sonic acoustic pressure waves (1 pulse per second; up to 80 to 120 pulses per catheter) delivering an effective peak pressure equivalent to ~50 atm across the vessel wall.
  • Unique Advantages: Acoustic waves pass safely through compliant soft tissue while inducing multi-plane longitudinal and circumferential fractures in both superficial intimal and DEEP medial calcium. Unlike atherectomy, IVL requires no specialized wire, allows a side-branch protection wire to remain safely in place during bifurcation treatment, and has minimal risk of slow-flow/no-reflow (because calcium is fractured in situ rather than sanded into embolic debris) or perforation.
  • Combined “RotaTripsy” (or “Orbital-Tripsy”): When a severely calcified lesion is balloon-uncrossable, initial Rotational Atherectomy with a small (1.25 or 1.5 mm) burr creates a channel for the IVL balloon, which then fractures the remaining deep thick circumferential calcium.

VILANDMARK CLINICAL TRIALS AND ALGORITHMIC APPROACH

  • PREPARE-CALC Trial (2018): Demonstrated higher procedural success (98% vs. 81%) with upfront Rotational Atherectomy compared to modified (cutting/scoring) balloons in severely calcified lesions, largely due to a 16% bailout crossover rate from balloons to Rotablator.
  • ISAR-CALC Trials: In balloon-crossable severely calcified lesions, the Super-High-Pressure Balloon (OPN NC) achieved good stent expansion on OCT, comparable to other balloon-based plaque-modification strategies.
  • DISRUPT CAD III (2020) and DISRUPT CAD IV (2021) Trials: Prospective pivotal studies demonstrating 92.4 percent procedural success and low 30-day MACE (7.8%) with Intravascular Lithotripsy (IVL), with OCT confirming multi-plane calcium fractures in 67 to 70 percent of lesions and identical stent expansion regardless of calcium eccentricity.
  • ECLIPSE Trial (TCT 2024 — Largest Calcified Lesion RCT, n = 2,005): Randomized patients with severely calcified, balloon-crossable coronary lesions to upfront Orbital Atherectomy versus Conventional Balloon Angioplasty (including NC, cutting/scoring balloons) prior to DES implantation. Orbital Atherectomy did NOT reduce 1-year Target Vessel Failure (11.5% vs. 10.0%; p = 0.28) and did NOT significantly increase post-PCI Minimum Stent Area on OCT (7.67 vs. 7.42 mm2; p = 0.08) —confirming that routine upfront atherectomy is not superior to meticulous intravascular-imaging-guided balloon preparation in balloon-crossable lesions.
  • Stepwise Clinical Algorithm:
    • Balloon-Uncrossable Lesion: Perform Rotational Atherectomy (or ELCA if RotaWire cannot cross).
    • Balloon-Crossable with OCT Calcium Score 0 to 3: High-pressure NC, Cutting/Scoring, or OPN Balloon; verify 1:1 balloon expansion before stenting.
    • Balloon-Crossable with OCT Calcium Score 4 (Arc >180°, Thickness >0.5 mm, Length >5 mm) or Deep/Bifurcation Calcium: Intravascular Lithotripsy (IVL) (or Atherectomy/OPN balloon).
    • Calcified Nodule: Rotational/Orbital Atherectomy or IVL (hinge fracture) with high-pressure NC post-dilation.
    • Refractory Stent Under-Expansion (Calcium Behind Deployed Stent): OPN Super-High-Pressure Balloon, IVL, or ELCA (avoid high-speed Rotablator inside an unexpanded stent unless extreme bailout “Rota-ablation” is required by expert operators).

Key references

  • Fujino A, Mintz GS, Matsumura M, et al.: A new optical coherence tomography-based calcium scoring system to predict stent underexpansion, EuroIntervention, 2018.
  • Hill JM, Kereiakes DJ, Shlofmitz RA, et al. (DISRUPT CAD III Investigators): Intravascular lithotripsy for treatment of severely calcified coronary artery disease, Journal of the American College of Cardiology, 2020.
  • Kirtane AJ, Stone GW, et al. (ECLIPSE Investigators): Orbital Atherectomy vs. Conventional Balloon Angioplasty Before Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The ECLIPSE Randomized Trial, TCT / Circulation / Lancet, 2024/2025.
  • Riley RF, Patel MP, Abbott JD, et al.: SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions, Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), 2024.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.